AQR Capital Management - SAGENT PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$491,000
+124.2%
32,757
+81.6%
0.00%
Q1 2016$219,000
-11.7%
18,036
+15.7%
0.00%
Q4 2015$248,000
-50.6%
15,590
-24.6%
0.00%
-100.0%
Q2 2015$502,000
-8.1%
20,664
-12.1%
0.00%0.0%
Q1 2015$546,000
+67.5%
23,500
+80.8%
0.00%0.0%
Q4 2014$326,000
-19.1%
13,000
-34.2%
0.00%0.0%
Q3 2013$403,00019,7660.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders